Windlas Biotech Share Price

₹ 912.90

+₹36.80 (4.20%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: WINDLAS
|
Pharmaceuticals

Windlas Biotech Share Price Today

As of 3 Nov 2026, Windlas Biotech share price is ₹912.90. The stock opened at ₹874.90, compared to its previous close of ₹876.10. During today's trading session, Windlas Biotech share price moved in the range of ₹861.00 to ₹918.80, with an average price of ₹889.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹697.40 and a high of ₹1,181.90. On the performance front, Windlas Biotech share price has increased by 6.79% over the last six months and is down 3.79% on a year-on-year basis.

Share price over the last 1 day rose from 872.85 to 912.90, ranging between 861.00 and 917.00.
₹861.00
4.20% up today
₹918.80
1D LOW
1D HIGH

Windlas Biotech Stock Insights

Latest Earning
Op Profit TrendUp by 0.95% QoQ
Latest Earning
Net Profit TrendUp by 6.60% QoQ
Latest Earning
Revenue TrendUp by 2.18% QoQ
Stock Performance
OutperformingBeat Nifty by 7.61 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 1.31%
Shareholding Pattern
FIIFII increased stake by 2.02%
Windlas Biotech stock performance
Open₹874.90
High₹918.80
Low₹861.00
Prev. close₹876.10
Windlas Biotech trading activity
Volume65,044
Average traded price₹888.58
Last traded time03:29:47 02 Nov
Last traded quantity2
Circuit
L
H
₹727.75
₹1,091.55
52-week
L
H
₹697.40
₹1,181.90
Mkt Cap Cr
1,810.31
P/E
23.42
P/B
2.68
ROA
10.73%
ROE
12.23%
ROCE
15.82%
Quick Ratio
1.76
EV/EBITDA
12.98

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Windlas Biotech has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Windlas Biotech appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Windlas Biotech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Windlas Biotech Company Background

ISIN
INE0H5O01029
Sector Market Cap
₹ 1,810.31 Cr

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.

Windlas Biotech Financial Highlights

  • Revenue: Windlas Biotech reported revenue of ₹921.89 crore in FY26 vs ₹777.90 crore in FY25. It showed an increase of 18.51% on a yearly basis.
  • Operating Profit: Windlas Biotech reported an operating profit of ₹86.98 crore in FY26 vs ₹79.76 crore in FY25. It showed an increase of 9.05% on a year-on-year basis.
  • Net Profit: Windlas Biotech reported a net profit of ₹66.46 crore in FY26 vs ₹60.99 crore in FY25. It showed an increase of 8.97% on a yearly basis.

Windlas Biotech Quarterly Result Highlights

  • Windlas Biotech reported revenue of ₹242.85 crore in Mar 2026, compared with ₹237.67 crore in Dec 2025, representing an increase of 2.18% on a quarter-on-quarter (QoQ) basis.
  • Windlas Biotech reported an operating profit of ₹20.16 crore in Mar 2026, compared with ₹19.97 crore in Dec 2025, representing an increase of 0.95% on a quarter-on-quarter (QoQ) basis.
  • Windlas Biotech reported a profit of ₹15.99 crore in Mar 2026, compared with ₹15.00 crore in Dec 2025, reflecting an increase of 6.60% on a QoQ basis.
  • The earnings per share (EPS) of Windlas Biotech stood at ₹31.60 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
63.31%
FII
2.08%
Other DII
4.14%
Retail and other
27.36%
Mutual funds
3.10%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.60%
May 20260.99%
Jun 20262.04%
Sep 20262.08%

Windlas Biotech Investment Returns

1 day
+3.83%
1 week
+3.08%
1 month
-15.96%
1 year
-3.79%
3 years
+147.69%
5 years
+192.63%

Windlas Biotech Share Price History

Windlas Biotech share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹874.90 / ₹909.65
+3.83%
30 Oct 26
₹920.80 / ₹876.10
-5.12%
29 Oct 26
₹899.70 / ₹923.40
+3.90%
28 Oct 26
₹883.30 / ₹888.70
+1.29%
Show more

Windlas Biotech Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹904.09₹759.88₹630.96₹513.08
Other Income₹17.80₹18.02₹13.47₹9.97
Total Revenue₹921.89₹777.90₹644.42₹523.05
Total Expenses₹834.92₹698.14₹567.33₹466.01
Profit Before Tax₹86.98₹79.76₹77.09₹57.04
Tax₹20.52₹18.76₹18.90₹14.41
Profit After Tax₹66.46₹60.99₹58.19₹42.63
EPS - Basic₹31.60₹29.19₹27.97₹19.70
EPS - Diluted₹31.15₹28.87₹27.88₹19.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹86.98₹79.76₹77.09₹57.04
Income before WC changes₹123.72₹98.16₹83.66₹64.36
Change in Assets-₹66.36-₹57.64-₹5.52-₹25.36
Change in Liabilities₹62.73₹48.54₹49.47₹31.68
Change in WC-₹3.63-₹9.09₹43.95₹6.32
Cash flow from Operations₹104.93₹68.19₹108.96₹60.97
Cash flow from Investing-₹91.79-₹74.06-₹92.07-₹14.11
Cash flow from Financing-₹13.03₹1.01-₹15.29-₹43.74
Total Cash Flow₹0.11-₹4.86₹1.60₹3.12
Cash (Start of the year)₹0.42₹5.29₹3.69₹0.57
Cash (End of the year)₹0.54₹0.42₹5.29₹3.69

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹280.50₹235.02₹194.92₹175.44
Current Assets₹626.85₹525.43₹431.29₹353.54
Total Assets₹907.35₹760.45₹626.21₹528.98
Current Liabilities₹320.93₹249.44₹171.75₹121.24
Net Current Asset₹305.92₹275.98₹259.54₹232.29
Non-Current Liabilities₹5.58₹5.24₹4.52₹5.46
Equity Capital₹580.84₹505.77₹449.94₹402.27
Total Equity & Liabilities₹907.35₹760.45₹626.21₹528.98

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹904.09₹759.88₹630.96₹513.08
Other Income₹17.80₹17.65₹13.47₹9.97
Total Revenue₹921.89₹777.52₹644.42₹523.05
Total Expenses₹834.96₹698.13₹567.40₹465.99
Profit Before Tax₹86.93₹79.39₹77.02₹57.06
Tax₹20.50₹18.75₹18.88₹14.41
Profit After Tax₹66.44₹60.65₹58.14₹42.64
EPS - Basic₹31.59₹29.03₹27.95₹19.71
EPS - Diluted₹31.14₹28.71₹27.86₹19.71

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹86.93₹79.39₹77.02₹57.06
Income before WC changes₹123.67₹97.81₹83.62₹64.40
Change in Assets-₹66.36-₹57.64-₹5.52-₹25.36
Change in Liabilities₹62.74₹48.93₹49.43₹31.66
Change in WC-₹3.61-₹8.71₹43.91₹6.29
Cash flow from Operations₹104.93₹68.23₹108.91₹60.98
Cash flow from Investing-₹91.79-₹74.06-₹92.07-₹14.11
Cash flow from Financing-₹13.03₹1.01-₹15.29-₹43.74
Total Cash Flow₹0.11-₹4.82₹1.56₹3.13
Cash (Start of the year)₹0.42₹5.24₹3.69₹0.55
Cash (End of the year)₹0.53₹0.42₹5.24₹3.69

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹280.50₹235.32₹194.92₹175.47
Current Assets₹626.84₹525.13₹431.24₹353.54
Total Assets₹907.34₹760.45₹626.16₹529.01
Current Liabilities₹320.93₹249.42₹171.35₹120.88
Net Current Asset₹305.92₹275.70₹259.89₹232.65
Non-Current Liabilities₹5.58₹5.24₹4.52₹5.46
Equity Capital₹580.83₹505.79₹450.29₹402.67
Total Equity & Liabilities₹907.34₹760.45₹626.16₹529.01
* All values are in INR Crore
Windlas Biotech market depth
Bid quantityBid priceAsk priceAsk quantity
00909.6524
0000
0000
0000
0000
Total bid quantity0
Total ask quantity24
Windlas Biotech technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
35.28
Neutral
ATR (14)
37.66
Neutral
STOCH(9,6)
23.09
Neutral
STOCH RSI (14)
58.58
Neutral
ADX(9)
47.26
Bearish
UO(9)
49.12
Neutral
ROC(12)
-6.32
Bearish
WillR(14)
-85.04
Bullish
Period
Simple value
Exponential vaue
5D
889.62
891.58
10D
892.6
902.32
20D
937.53
935.55
50D
1017.89
967.39
100D
938.51
942.49
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct1L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Windlas Biotech
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Windlas Biotech

Fund name
AUM
UTI Healthcare Fund
1.13%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
0.95%
ICICI Prudential Smallcap Fund
0.24%

Windlas Biotech Returns Calculator

Ex-date: 16 Jul 2026

Windlas Biotech Latest News

2 months ago
Century Enka, Antelopus Selan, EMS, Nicco Parks shares spurt amid heavy volumes; check full list
Showing news item 1 of 1

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Windlas Biotech Share Price FAQs

Please be aware that Windlas Biotech stock prices are subject to continuous fluctuations due to various factors.